
In an interview with Pharmacy Times, Thomas Hope, MD, explains how earlier consideration of peptide receptor radionuclide therapy in neuroendocrine tumors makes treatment scheduling and continuity of care essential opportunities for pharmacists.
By supporting pharmacy students at Howard University, the fellowship hopes to expand the number of pharmacists of color in industry.
This month, we spoke with Earl Ettienne, BScPharm, MBA, from Howard University, and Dietmar Berger, MD, PhD, of Sanofi, about their recently-announced partnership and fellowship program. By supporting pharmacy students at Howard University, Ettienne said the fellowship hopes to expand the number of pharmacists of color in industry.
Are you interested in more content like this?





